Cargando…
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes
New markers based on PSA isoforms have recently been developed to improve prostate cancer (PCa) diagnosis. However, novel approaches are still required to differentiate aggressive from non-aggressive PCa to improve decision making for patients. PSA glycoforms have been shown to be differentially exp...
Autores principales: | Llop, Esther, Ferrer-Batallé, Montserrat, Barrabés, Sílvia, Guerrero, Pedro Enrique, Ramírez, Manel, Saldova, Radka, Rudd, Pauline M., Aleixandre, Rosa N., Comet, Josep, de Llorens, Rafael, Peracaula, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893645/ https://www.ncbi.nlm.nih.gov/pubmed/27279911 http://dx.doi.org/10.7150/thno.15226 |
Ejemplares similares
-
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum
por: Llop, Esther, et al.
Publicado: (2018) -
Characterisation of the main PSA glycoforms in aggressive prostate cancer
por: Gratacós-Mulleras, Anna, et al.
Publicado: (2020) -
Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection
por: Ferrer-Batallé, Montserrat, et al.
Publicado: (2017) -
Altered Glycosylation in Tumours Focused to Cancer Diagnosis
por: Peracaula, Rosa, et al.
Publicado: (2008) -
Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera
por: Duran, Adrià, et al.
Publicado: (2022)